STRI (Stem Cell Treatment & Research Institute), US Patent Registration of the Nerve Cell Differentiation Technology of nEPS (newly Elicited Pluripotent Stem Cell without Side Effects by natural compounds)
STRI Successfully Treated Stroke Symptoms Using Stem Cell
STRI, Registration of Liver Cell Differentiation Patent in Korea… First in Mesenchymal Stem Cell
STRI (Stem Cell Treatment & Research Institute) Registered a US Patent for its Newly Elicited Pluripotent Stem Cell without Side Effects by Natural Compounds (nEPS)
bBHC, U.S. Patent Registration of the Pluripotent Stem Cell without Side Effects
SEOUL, South Korea, Feb. 29, 2016 /PRNewswire/ — STC-Stem Cell Treatment & Research Institute (“STRI” or “the Company”) Chairman Kye-ho Lee announced..
STRI and Fraunhofer kicks off with a pilot study at Halle Germany, using nEPS(newly Elicited Pluripotent Stem cells without side effects by natural compound) to treat Alzheimer’s Study. STRI and Fraunhofer kicks off with a pilot study at Halle…
STRI and Fraunhofer kicks off with a pilot study at Halle Germany, using nEPS(newly Elicited Pluripotent Stem cells without side effects by natural compound) to treat Alzheimer’s Study. STRI and Fraunhofer kicks off with a pilot study at Halle…
Japan, the United States, and Europe are devoting their efforts to stem cell research… The newly elicited pluripotent stem cell without side effects invented by STRI has begun clinical trials.
The patented technology uses latest cell differentiation and cultivation technology, along with low molecular weight compound extracted from a natural compound.
